1. Home
  2. SMBK vs AMPH Comparison

SMBK vs AMPH Comparison

Compare SMBK & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SmartFinancial Inc.

SMBK

SmartFinancial Inc.

HOLD

Current Price

$51.88

Market Cap

887.9M

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$23.59

Market Cap

885.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMBK
AMPH
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.9M
885.4M
IPO Year
2000
2005

Fundamental Metrics

Financial Performance
Metric
SMBK
AMPH
Price
$51.88
$23.59
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$43.17
$28.38
AVG Volume (30 Days)
87.6K
326.4K
Earning Date
04-20-2026
05-07-2026
Dividend Yield
0.77%
N/A
EPS Growth
39.25
N/A
EPS
1.77
0.81
Revenue
N/A
$719,887,000.00
Revenue This Year
$17.59
$6.90
Revenue Next Year
$10.30
$4.64
P/E Ratio
$28.74
$28.44
Revenue Growth
N/A
N/A
52 Week Low
$33.01
$16.65
52 Week High
$54.14
$29.52

Technical Indicators

Market Signals
Indicator
SMBK
AMPH
Relative Strength Index (RSI) 54.59 66.77
Support Level $50.93 $18.36
Resistance Level $53.71 $24.35
Average True Range (ATR) 1.11 0.69
MACD -0.06 0.06
Stochastic Oscillator 67.67 81.95

Price Performance

Historical Comparison
SMBK
AMPH

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: